Skip to content
healthcare.dev

Cysto-Conray II

NDC 0019-0862, Iothalamate meglumine, injection, from Liebel-Flarsheim Company LLC.

Product NDC
0019-0862
Status
Listed
Labeler
Liebel-Flarsheim Company LLC
Dosage form
INJECTION
Route
URETERAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA017057
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0019-0862 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IOTHALAMATE MEGLUMINE172 mg/mL

Pharmacologic classes

Radiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]

Package NDCNDC-11Package
0019-0862-500001908625012 BOTTLE, GLASS in 1 BOX (0019-0862-50) / 250 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8841ab4d-674d-4beb-88a5-13e35f6005cc
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0019-0862

Use it

Look up 0019-0862 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0019-0862 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0019-0862. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.